Evidence map›Paper›PMID 12221292›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Gbeta gamma -independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1.

Ying-Hong Feng, Yan Sun, Janice G Douglas

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. The Angiotensin ATPharmacological reviews · 2022
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Dimerization of ATCurrent hypertension reports · 2018
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Angiotensin II activates AMPK for execution of apoptosis through energy-dependent and -independent mechanisms.American journal of physiology. Lung cellular and molecular physiology · 2011
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Rab1 GTPase and dimerization in the cell surface expression of angiotensin II type 2 receptor.The Journal of pharmacology and experimental therapeutics · 2009
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ying-Hong FengDepartment of Medicine, Case Western Reserve University School of Medicine, and University Hospital of Cleveland, 10900 Euclid Avenue, Cleveland, OH 44106-4982, USA. yxf6@po.cwru.edu
Yan Sun
Janice G Douglas
Case Western Reserve University · USUniversity School · US

Funding

VASOACTIVE HORMONES: RECEPTORS AND SIGNALING MECHANISMSP01HL041618 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI HOPFER, ULRICH · 1989 to 2004
$6.7M
NHLBI NIH HHS HL41618NHLBI NIH HHS P01 HL041618
6 · The paper itself

Abstract

Conventional mode of activation of SH2 domain-containing phosphatase 1 (SHP-1) by a single transmembrane (TM) inhibitory receptor such as killer cell inhibitory receptor, Fcgamma receptor type IIb1, and paired Ig-like receptors of inhibitory types requires tyrosine phosphorylation of immunoreceptor tyrosine-based inhibitory (ITIM) motifs in the cytoplasmic domains of the inhibitory receptors. Contrary to this paradigm, AT(2), a G protein-coupled 7TM receptor that does not undergo tyrosine phosphorylation in response to angiotensin II (Ang II) stimulation, also activates SHP-1. Here we show that SHP-1 constitutively and physically associates with AT(2) receptor in transfected COS-7 cells. On stimulation by Ang II, SHP-1 becomes activated and dissociated from AT(2) receptor, independent of pertussis toxin. Cotransfection of transducin G(betagamma) inhibits SHP-1/AT(2) association and the SHP-1 activation, whereas cotransfection of C-terminal of beta-adrenergic receptor kinase, which abrogates G(betagamma) signaling, facilitates SHP-1 activation. Surprisingly, SHP-1/AT(2) association and the SHP-1 activation requires the presence of G(alphas) as shown by differential coimmunoprecipitation, dominant negative G(alphas), constitutively active G(alphas), and G(alpha) peptides. A mutant AT(2) receptor D141A-R142L that is inactive in G(alpha) protein activation constitutively associates with SHP-1 and activates it. Together, these results indicate that G(alphas) alone, rather than exclusively in the form of G(alphabetagamma) heterotrimer may facilitate signal transduction for G protein-coupled receptors, suggesting a novel mechanism distinct from the classic paradigm of heterotrimeric G proteins. The AT(2)-mediated ITIM-independent activation of SHP-1 that is distinct from the conventional mode of activation, may represent a general paradigm for activation of SHP-1/2-class tyrosine phosphatases by G protein-coupled receptors.

Indexed as

GTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsAmino Acid SequenceAnimalsbeta-Adrenergic Receptor KinasesCHO CellsCOS CellsCricetinaeCyclic AMP-Dependent Protein KinasesEnzyme ActivationHeterotrimeric GTP-Binding ProteinsIntracellular Signaling Peptides and ProteinsIn Vitro TechniquesMutationProtein Phosphatase 1Protein Structure, Tertiarybeta-Adrenergic Receptor KinasesCyclic AMP-Dependent Protein KinasesG-protein Beta gammaGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsHeterotrimeric GTP-Binding ProteinsIntracellular Signaling Peptides and ProteinsProtein Phosphatase 1Protein Tyrosine Phosphatase, Non-Receptor Type 6Protein Tyrosine PhosphatasesPtpn6 protein, ratReceptor, Angiotensin, Type 2Receptors, AngiotensinReceptors, Cell SurfaceRecombinant Proteins

Identifiers

PMID12221292
PMCPMC129396
OpenAlexW2016656766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.